24 HR nicotine 0.292 MG/HR Transdermal System [Habitrol] — RxCUI 207734
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nicotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
- You need to stop smoking completely from the moment you start the patch — not cut back gradually. Even when you're not wearing it, nicotine stays in your skin and keeps releasing i...
- Do I need to quit smoking completely on day one, or can I cut back gradually while using the patch?
- You can do either — it depends on how your body reacts. If morning cigarette cravings are strong, wearing it for the full 24 hours can help. But if you're getting vivid dreams or h...
- Can I wear the patch overnight, or should I take it off at bedtime?
🕸️ Concept Web — How 24 HR nicotine 0.292 MG/HR Transdermal System [H... Connects
RxCUI 207734 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nicotine
7407IN
-
Nicotine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Habitrol
203781BN
-
Habitrol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nicotine Transdermal System
1805957SCDF -
Nicotine Topical Product
1158682SCDG -
Nicotine Transdermal Product
1295678SCDG -
Nicotine Transdermal System [Habitrol]
1805991SBDF -
Habitrol Topical Product
1176088SBDG -
Habitrol Transdermal Product
1296142SBDG -
Transdermal System
316987DF -
Topical Product
1151122DFG - +1 more in this family
-
Nicotine Transdermal System
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
24 HR nicotine 0.292 MG/HR Transdermal System
198031SCD -
Nicotine 0.292 MG/HR
345787SCDC -
Nicotine 0.292 MG/HR [Habitrol]
568479SBDC
-
24 HR nicotine 0.292 MG/HR Transdermal System
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
24 HR nicotine 0.292 MG/HR Transdermal System
SCD · 198031 -
{14 (24 HR nicotine 0.292 MG/HR Transdermal System) / 14 (24 HR nicotine 0.583 MG/HR Transdermal System) / 28 (24 HR nicotine 0.875 MG/HR Transdermal System) } Pack
GPCK · 892244 -
Nicotine 0.292 MG/HR
SCDC · 345787 -
Nicotine Transdermal System
SCDF · 1805957 -
Nicotine Topical Product
SCDG · 1158682 -
Nicotine Transdermal Product
SCDG · 1295678
Brand-Name Concepts
-
Nicotine 0.292 MG/HR [Habitrol]
SBDC · 568479 -
Nicotine Transdermal System [Habitrol]
SBDF · 1805991 -
Habitrol Topical Product
SBDG · 1176088 -
Habitrol Transdermal Product
SBDG · 1296142 -
Habitrol
BN · 203781
📦 FDA Products & Package NDCs
3 products · 7 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55741-0446-70 | 7 PATCH in 1 CARTON (55741-446-70) / 24 h in 1 PATCH | Habitrol Step 3 | Dr. Reddy's Laboratories Inc. | 2019-07-01 |
| 55741-0446-74 | 14 PATCH in 1 CARTON (55741-446-74) / 24 h in 1 PATCH | Habitrol Step 3 | Dr. Reddy's Laboratories Inc. | 2019-06-15 |
| 55741-0447-70 | 7 PATCH in 1 CARTON (55741-447-70) / 24 h in 1 PATCH | Habitrol Step 2 | Dr. Reddy's Laboratories Inc. | 2019-07-01 |
| 55741-0447-74 | 14 PATCH in 1 CARTON (55741-447-74) / 24 h in 1 PATCH | Habitrol Step 2 | Dr. Reddy's Laboratories Inc. | 2019-04-22 |
| 55741-0448-28 | 28 PATCH in 1 CARTON (55741-448-28) / 24 h in 1 PATCH | Habitrol Step 1 | Dr. Reddy's Laboratories Inc. | 2019-07-01 |
| 55741-0448-70 | 7 PATCH in 1 CARTON (55741-448-70) / 24 h in 1 PATCH | Habitrol Step 1 | Dr. Reddy's Laboratories Inc. | 2019-06-15 |
| 55741-0448-74 | 14 PATCH in 1 CARTON (55741-448-74) / 24 h in 1 PATCH | Habitrol Step 1 | Dr. Reddy's Laboratories Inc. | 2019-06-15 |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.